Wheat right for Proteome

By Dylan Bushell-Embling
Thursday, 03 July, 2008

Sydney's Proteome Systems [ASX: PXL] has sold an exclusive license for its DiagnostIQ test device to Bayer CropScience.

Under the agreement Bayer and Proteome will also collaborate to produce new products based on the technology.

Bayer will own the commercialisation rights for the products, but will pay PXL product developments and license fees as well on royalties on each sale.

Bayer and Proteome have already collaborated to produce WheatRite, a quality assurance test that can be completed in three minutes.

WheatRite will be launched this year, and is initially to be sold in Canada, with expansion to other markets including Australia to occur later.

Content from other channels on our network

Increasing sensor life in harsh conditions

Enabling OT continuous monitoring

Central Coast Council completes first remote sewer inspection

Ghost Bat a major milestone for local defence manufacturing

From smart to vulnerable: The hidden costs of the digitalisation of utilities

GNT shows how plant-based colours can liven up snacks

Getting a handle on a shrink bag for turkey

Six on the shelf: from frozen snacks to GF treats

Visibly conveying freshly roasted coffee direct to the consumer

Sobering up with the latest wine trends

Recycled water to keep Victorian sporting grounds green

Productivity Summit announcement welcomed

ABB receives EPD status for gearless mill drive ring motor

From Crisis to Control: AI Offers New Hope for Water Management

Urban mining to diversify Australia's critical metal supply chain

Wheat right for Proteome

Organoid platform enables closer study of bat-borne viruses

Global study finds 250 genes linked to OCD

TGA approves therapy for paediatric growth hormone deficiency

Content from other channels on our network